Tuesday, November 30, 2021


BioCubaFarma highlights transparency in development of Cuban vaccines

BioCubaFarma highlights transparency in development of Cuban vaccines

Havana, Oct 4 (Prensa Latina) The Biotechnology and Pharmaceutical Industries Group (BioCubaFarma) highlighted the transparency that characterizes the vaccine development process in Cuba, where 48.5 of citizens have been immunized against Covid-19.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The director of BioCubaFarma, Eduardo Martinez tweeted explaining that each stage was informed to the population through the media and institutional digital platforms.

The results were presented at international events held virtually, Martinez stressed.

Part of these results, added the director, are published in scientific journals and other works continue to be sent.

Martínez pointed out that there is a fluid exchange with the World Health Organization and the Pan American Health Organization, international entities that already have data on the results obtained in their hands.

Cuba has three Covid-19 vaccines and one of them, Abdala, has already received authorization for emergency use in the country, as well as Sovereign 02 for the pediatric age population.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.